The case for boring scents.

There's a temptation, when you start a candle brand, to make the scents sound complicated. Tonka and oud and something rare from a coast in Madagascar. The idea is that complexity reads as luxury.

We went the other way.

Cravista's launch range is built on three ingredients you can pronounce: lavender, rosemary, and bergamot. There are reasons that go beyond cost, and the reasons matter.

What "boring" actually means

A boring scent, in this context, isn't one that lacks character. It's one whose character is settled. Lavender has been studied in human-subjects research for thirty years. Rosemary for nearly as long. Bergamot has a history that predates clinical research and continues inside it. These ingredients have biographies. We know roughly what they do, what they don't do, and where the evidence ends.

That last part matters. The research on lavender and sleep, for example, is consistent enough to take seriously and limited enough not to overclaim.¹ We can say there is a body of work suggesting that the inhalation of linalool — lavender's primary aromatic compound — is associated with reduced cortisol response and slightly faster sleep onset. We can't say lavender will help you sleep. The first sentence is honest. The second is a marketing claim, and we don't make those.

The alternative

Complex blends are harder to defend. If a candle contains seventeen ingredients chosen for evocative names rather than evidence, the brand is asking the buyer to trust the brand's taste. Sometimes that trust is earned. Often it isn't.

Boring ingredients are easier to defend because the defense doesn't require trust. It requires citations.

The trade

What you lose with restraint is novelty. What you gain is the ability to be specific. We can explain, in plain language, why each oil is in each blend. The Morning Ritual candle has bergamot because there is research on bergamot and alertness states.² The Evening Ritual candle has lavender for the reasons described above. The Focus Ritual has rosemary because rosemary's primary aromatic compound, 1,8-cineole, has been measured in human bloodstream after inhalation and correlated with performance on cognitive tasks.³

None of this is a promise. All of it is reasoning we can show.

What we won't do

We won't claim the candles are therapeutic. We won't suggest they treat anything. We won't borrow vocabulary from medicine. We're a brand that makes candles. The candles smell of well-studied things, and we tell you why.

That seemed like enough.